Imfinzi (durvalumab) - AstraZeneca
Keytruda (pembrolizumab) - Merck (MSD)
Tevimbra (tislelizumab-jsgr) - BeOne Medicines
LK101 - Likang Life Sci
http://clinicaltrials.gov/ct2/show/NCT05886439
 
Dec 9, 2025
 
Next